Hepatocellular necrosis, apoptosis, and proliferation after transcatheter arterial embolization or chemoembolization in a standardized rabbit model

Journal of Vascular and Interventional Radiology

Volumn 22, Issue 11, 2011, Pages 1606-1612

  Wang, Yong ^a   Zheng, Chuansheng ^a   Liang, Bin ^a   Zhao, Hui ^a   Qian, Jun ^a   Liang, Huimin ^a   Feng, Gansheng ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

alanine aminotransferase; ALT; aspartate aminotransferase; AST; polyvinyl alcohol; PVA; terminal deoxynucleotidyl transferasemediated deoxyuridine triphosphate nick end labeling; TNF; tumor necrosis factor; TUNEL

Indexed keywords

10 HYDROXYCAMPTOTHECIN; ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; IODINATED POPPYSEED OIL; KI 67 ANTIGEN; LIPIODOL ULTRA FLUID; POLYVINYL ALCOHOL; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; WATER;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; ARTIFICIAL EMBOLISM; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BILIRUBIN BLOOD LEVEL; CANCER TRANSPLANTATION; CELL PROLIFERATION; CHEMOEMBOLIZATION; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; CYTOKINE RELEASE; CYTOKINE RESPONSE; DIGITAL SUBTRACTION ANGIOGRAPHY; DRUG EFFECT; EXPERIMENTAL RABBIT; HEPATIC ARTERY; IMMUNOHISTOCHEMISTRY; INFLAMMATION; INFUSION; INTERMETHOD COMPARISON; LIVER CELL; LIVER CELL CARCINOMA; LIVER CELL DAMAGE; LIVER FUNCTION TEST; LIVER HISTOLOGY; LIVER INJURY; LIVER NECROSIS; MULTIMODALITY CANCER THERAPY; NICK END LABELING; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL;

ALANINE TRANSAMINASE; ANGIOGRAPHY, DIGITAL SUBTRACTION; ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; ASPARTATE AMINOTRANSFERASES; CAMPTOTHECIN; CARCINOMA, HEPATOCELLULAR; CELL PROLIFERATION; CHEMOEMBOLIZATION, THERAPEUTIC; EMBOLIZATION, THERAPEUTIC; HEPATIC ARTERY; IN SITU NICK-END LABELING; IODIZED OIL; KI-67 ANTIGEN; LIVER FUNCTION TESTS; LIVER NEOPLASMS, EXPERIMENTAL; LIVER REGENERATION; MAGNETIC RESONANCE IMAGING; NECROSIS; POLYVINYL ALCOHOL; RABBITS; TIME FACTORS; TOMOGRAPHY, X-RAY COMPUTED; TUMOR NECROSIS FACTOR-ALPHA;

EID: 80054925297     PISSN: 10510443     EISSN: 15357732     Source Type: Journal    
DOI: 10.1016/j.jvir.2011.08.005     Document Type: Article

References (37)

1. C. Camma, F. Schepis, and A. Orlando Transarterial chemoembolization for unresectable hepatocellular carcinoma: meta-analysis of randomized controlled trials Radiology 224 2002 47 54 (Pubitemid 34680374)
2. C.M. Lo, H. Ngan, and W.K. Tso Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma Hepatology 35 2002 1164 1171 (Pubitemid 34454013)
3. J.M. Llovet, and J. Bruix Systematic review of randomized trials for unresectable hepatocellular carcinoma: chemoembolization improves survival Hepatology 37 2003 429 442 (Pubitemid 36152543)
4. J.M. Llovet, M.I. Real, and X. Montana Arterial embolization or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial Lancet 359 2002 1734 1739 (Pubitemid 34607087)
5. O. Ernst, G. Sergent, and D. Mizrahi Treatment of hepatocellular carcinoma by transcatheter arterial chemoembolization: comparison of planned periodic chemoembolization and chemoembolization based on tumor response AJR Am J Roentgenol 172 1999 59 64 (Pubitemid 29028431)
6. K. Takayasu, S. Arii, and I. Ikai Prospective cohort study of transarterial chemoembolization for unresectable hepatocellular carcinoma in 8510 patients Gastroenterology 131 2006 461 469 (Pubitemid 44142456)
7. S. Wallace, Z. Kan, and C. Li Hepatic chemoembolization: clinical and experimental correlation Acta Gastroenterol Belg 63 2000 169 173 (Pubitemid 30445436)
8. A. Rutherford, and R.T. Chung Acute liver failure: mechanisms of hepatocyte injury and regeneration Semin Liver Dis 28 2008 167 174 (Pubitemid 351632956)
9. H. Malhi, G.J. Gores, and J.J. Lemasters Apoptosis and necrosis in the liver: a tale of two deaths? Hepatology 43 Suppl 2006 S31 S44
10. L. Marelli, R. Stigliano, and C. Triantos Transarterial therapy for hepatocellular carcinoma: which technique is more effective? A systematic review of cohort and randomized studies Cardiovasc Intervent Radiol 30 2007 6 25 (Pubitemid 44900485)
11. M. Pleguezuelo, L. Marelli, and M. Misseri TACE versus TAE as therapy for hepatocellular carcinoma Expert Rev Anticancer Ther 8 2008 1623 1641
12. A.O. Chan, M.F. Yuen, and C.K. Hui A prospective study regarding the complications of transcatheter intraarterial lipiodol chemoembolization in patients with hepatocellular carcinoma Cancer 94 2002 1747 1752 (Pubitemid 34241113)
13. W. Lu, Y. Li, X. He, and Y. Chen Transcatheter arterial chemoembolization for hepatocellular carcinoma in patients with cirrhosis: evaluation of two kinds of dosages of anticancer drugs and analysis of prognostic factors Hepatogastroenterology 50 2003 2079 2083 (Pubitemid 37467998)
14. B. Liang, C. Zheng, and G. Feng Experimental evaluation of inhibitory effect of 10-hydroxycamptothecin on hypoxia-inducible factor-1α expression and angiogenesis in liver tumors after transcatheter arterial embolization J Vasc Interv Radiol 21 2010 1565 1572
15. S. Suzuki, L.H. Toledo-Pereyra, F.J. Rodriguez, and D. Cejalvo Neutrophil infiltration as an important factor in liver ischemia and reperfusion injury Modulating effects of FK506 and cyclosporine Transplantation 55 1993 1265 1272 (Pubitemid 23183235)
16. C. Gerlach, D.Y. Sakkab, and T. Scholzen Ki-67 expression during rat liver regeneration after partial hepatectomy Hepatology 26 1997 573 578 (Pubitemid 27392346)
17. S. Kobayashi, Y. Nakanuma, and O. Matsui Histopathology of portal tracts in livers after transcatheter arterial chemo-embolization therapy for hepatocellular carcinoma J Gastroenterol Hepatol 9 1994 45 54 (Pubitemid 24041948)
18. S. Miyayama, T. Mitsui, and Y. Zen Histopathological findings after ultraselective transcatheter arterial chemoembolization for hepatocellular carcinoma Hepatol Res 39 2009 374 381
19. J.S. Yu, K.W. Kim, and M.S. Park Bile duct injuries leading to portal vein obliteration after transcatheter arterial chemoembolization in the liver: CT findings and initial observations Radiology 221 2001 429 436
20. Y. Yamashita, M. Torashima, and T. Oguni Liver parenchymal changes after transcatheter arterial embolization therapy for hepatoma: CT evaluation Abdom Imaging 18 1993 352 356 (Pubitemid 23246588)
21. K.N. Khan, K. Nakata, and Y. Kusumoto Evaluation of nontumorous tissue damage by transcatheter arterial embolization for hepatocellular carcinoma Cancer Res 51 1991 5667 5671
22. J. Chung, J.S. Yu, and J.J. Chung Haemodynamic events and localised parenchymal changes following transcatheter arterial chemoembolisation for hepatic malignancy: interpretation of imaging findings Br J Radiol 83 2010 71 81
23. J. Li, D.Y. Hu, and Q. Chu Cell apoptosis and regeneration of hepatocellular carcinoma after transarterial chemoembolization World J Gastroenterol 10 2004 1876 1880 (Pubitemid 39029283)
24. E. Caturelli, D.A. Siena, and S. Fusilli Transcatheter arterial chemoembolization for hepatocellular carcinoma in patients with cirrhosis: evaluation of damage to nontumorous liver tissuelong-term prospective study Radiology 215 2000 123 128 (Pubitemid 30190520)
25. N. Nakao, M. Ohnishi, and T. Shimada Transcatheter hepatic arterial embolization with Avitene in dogs Cardiovasc Intervent Radiol 14 1991 124 128
26. Z. Kan, M. Sato, and K. Ivancev Distribution and effect of iodized poppyseed oil in the liver after hepatic artery embolization: experimental study in several animal species Radiology 186 1993 861 866 (Pubitemid 23073535)
27. F. Farinati, N. De Maria, and C. Marafin Unresectable hepatocellular carcinoma in cirrhosis: survival, prognostic factors, and unexpected side effects after transcatheter arterial chemoembolization Dig Dis Sci 41 1996 2332 2339
28. S. Kanzler, and P.R. Galle Apoptosis and the liver Semin Cancer Biol 10 2000 173 184 (Pubitemid 30611679)
29. L.M. Colletti, D.G. Remick, and G.D. Burtch Role of tumor necrosis factor-alpha in the pathophysiologic alternations after hepatic ischemia/reperfusion injury in the rat J Clin Invest 85 1990 1936 1943 (Pubitemid 20192970)
30. A.M. Diehl Cytokine regulation of liver injury and repair Immunol Rev 174 2000 160 171 (Pubitemid 30201387)
31. P.J. Kneuertz, S.K. Maithel, C.A. Staley, and D.A. Kooby Chemotherapy-associated liver injury: impact on surgical management of colorectal cancer liver metastases Ann Surg Oncol 18 2011 181 190
32. K. Tanaka, T. Kumamoto, and R. Matsuyama Influence of chemotherapy on liver regeneration induced by portal vein embolization or first hepatectomy of a staged procedure for colorectal liver metastases J Gastrointest Surg 14 2010 359 368
33. Y. Tanaka, N. Nagasue, and R. Kanashima Effect of doxorubicin on liver regeneration and host survival after two-thirds hepatectomy in rats Cancer 49 1982 19 24 (Pubitemid 12196130)
34. C. Sturesson, I. Keussen, and K.G. Tranberg Prolonged chemotherapy impairs liver regeneration after portal vein occlusion - an audit of 26 patients Eur J Surg Oncol 36 2010 358 364
35. A. Rickenbacher, M.L. DeOliveira, and Y. Tian Arguments against toxic effects of chemotherapy on liver injury and regeneration in an experimental model of partial hepatectomy Liver Int 31 2011 313 321
36. A.M. Covey, K.T. Brown, and W.R. Jarnagin Combined portal vein embolization and neoadjuvant chemotherapy as a treatment strategy for resectable hepatic colorectal metastases Ann Surg 247 2008 451 455
37. Y. Yokoyama, M. Nagino, and Y. Nimura Mechanisms of hepatic regeneration following portal vein embolization and partial hepatectomy: a review World J Surg 31 2007 367 374 (Pubitemid 46183525)